(Q40316045)

19 September 2017

title

siRNA targeting vaccinia virus double-stranded RNA binding protein [E3L] exerts potent antiviral effects (English)

1 reference

19 September 2017

vaccinia virus

1 reference

4

Matthias J Schnell

1 reference

19 September 2017

2

James P McGettigan

1 reference

19 September 2017

6

Roger J Pomerantz

1 reference

19 September 2017

Rajnish S Dave

1

1 reference

19 September 2017

Tazeen Qureshi

series ordinal

3

1 reference

19 September 2017

Giuseppe Nunnari

series ordinal

5

1 reference

19 September 2017

language of work or name

English

0 references

publication date

9 February 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

348

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

489-497

1 reference

Distinct patterns of IFN sensitivity observed in cells infected with vaccinia K3L- and E3L- mutant viruses

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

The N-terminal domain of the vaccinia virus E3L-protein is required for neurovirulence, but not induction of a protective immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

A system for stable expression of short interfering RNAs in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Vaccinia Virus B18R Gene Encodes a Type I Interferon-binding Protein That Blocks Interferon α Transmembrane Signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

RNA interference: antiviral defense and genetic tool

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Genetic uncoupling of the dsRNA-binding and RNA cleavage activities of the Escherichia coli endoribonuclease RNase III--the effect of dsRNA binding on gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

RNA interference: on the road to an alternate therapeutic strategy!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Site-directed mutagenic analysis of reovirus sigma 3 protein binding to dsRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Anti-apoptotic and oncogenic properties of the dsRNA-binding protein of vaccinia virus, E3L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Double-stranded RNA-activated protein kinase mediates virus-induced apoptosis: a new role for an old actor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Inhibition of the complement cascade by the major secretory protein of vaccinia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

The role of the PKR-inhibitory genes, E3L and K3L, in determining vaccinia virus host range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Double-stranded RNA-binding proteins could suppress RNA interference-mediated antiviral defences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Role of viral factor E3L in modified vaccinia virus ankara infection of human HeLa Cells: regulation of the virus life cycle and identification of differentially expressed host genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Defective interfering particles with covalently linked [±]RNA induce interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

A DNA vector-based RNAi technology to suppress gene expression in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

inferred from DOI database lookup

7 January 2021

based on heuristic

The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.01.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.01.013

1 reference

19 September 2017

1 reference